GlassScriptPhysician profile
Nicallina Abel
NPI 1043862592
$1,661.03
in general payments reported to CMS, 2019-2025
21 companies · $413 in 2025
The $413 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $49.21 · 2022: $213 · 2023: $389 · 2024: $597 · 2025: $413.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,399.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,398.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $694.45 | 2022-2025 | Watchman Flx, Watchman, Watchman Access System |
| Novo Nordisk INC | $135.16 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Glaxosmithkline, LLC. | $130.77 | 2022-2025 | Shingrix, Trelegy Ellipta, Arexvy |
| Lilly USA, LLC | $114.05 | 2023-2025 | Mounjaro, Jardiance, Emgality |
| Pfizer INC. | $112.79 | 2023-2025 | |
| Amgen INC. | $91.89 | 2022-2025 | Repatha, Otezla, Repatha |
| Merck Sharp & Dohme LLC | $57.30 | 2022-2024 | Gardasil 9, Gardasil, Capvaxive |
| Abbvie INC. | $52.95 | 2024-2025 | |
| Exact Sciences Corporation | $36.89 | 2025 | Cologuard Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $32.39 | 2021-2024 | |
| Astrazeneca Pharmaceuticals LP | $29.56 | 2022-2024 | Airsupra |
| Abbott Laboratories | $22.70 | 2021 | |
| Janssen Pharmaceuticals, INC | $21.33 | 2025 | Spravato |
| Azurity Pharmaceuticals, INC. | $21.05 | 2023 | Horizant |
| Phathom Pharmaceuticals, INC. | $17.96 | 2023 | Voquezna |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceutical Holding Company LTD. | $17.64 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $16.65 | 2025 | Austedo Xr |
| Genzyme Corporation | $14.92 | 2022 | |
| Amarin Pharma, INC. | $14.48 | 2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.44 | 2022 | |
| Daiichi Sankyo INC. | $11.66 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicallina Abel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.